Skip to main content
. Author manuscript; available in PMC: 2016 May 18.
Published in final edited form as: Oncogene. 2015 Mar 16;34(48):5912–5922. doi: 10.1038/onc.2015.41

Figure 1.

Figure 1

C/EBPβ expression increases in castration resistant prostate cancer. Individual patient (a) and mean (b) CEBPB expression as log2 median centered ratio for benign prostate, localized prostate cancer, and castration resistant prostate cancer (CRPC).